- Home
- FUFU vs NBY Comparison
FUFU vs NBY Comparison
Compare FUFU & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUFU
- NBY
- Stock Information
- Founded
- FUFU 2020
- NBY 2000
- Country
- FUFU Singapore
- NBY United States
- Employees
- FUFU N/A
- NBY N/A
- Industry
- FUFU
- NBY
- Sector
- FUFU
- NBY
- Exchange
- FUFU NYSE
- NBY Nasdaq
- Market Cap
- FUFU 744.5M
- NBY 3.3M
- IPO Year
- FUFU N/A
- NBY 2007
- Fundamental
- Price
- FUFU $4.84
- NBY $0.53
- Analyst Decision
- FUFU Strong Buy
- NBY Strong Buy
- Analyst Count
- FUFU 1
- NBY 1
- Target Price
- FUFU $7.00
- NBY $0.85
- AVG Volume (30 Days)
- FUFU 172.6K
- NBY 82.3K
- Earning Date
- FUFU 02-05-2025
- NBY 11-07-2024
- Dividend Yield
- FUFU N/A
- NBY N/A
- EPS Growth
- FUFU 1042.93
- NBY N/A
- EPS
- FUFU 0.23
- NBY N/A
- Revenue
- FUFU $452,743,012.00
- NBY $13,844,000.00
- Revenue This Year
- FUFU $66.38
- NBY N/A
- Revenue Next Year
- FUFU $5.25
- NBY $26.04
- P/E Ratio
- FUFU $20.62
- NBY N/A
- Revenue Growth
- FUFU 78.43
- NBY 15.40
- 52 Week Low
- FUFU $2.32
- NBY $0.36
- 52 Week High
- FUFU $18.32
- NBY $9.10
- Technical
- Relative Strength Index (RSI)
- FUFU 43.63
- NBY 39.55
- Support Level
- FUFU $5.06
- NBY $0.49
- Resistance Level
- FUFU $5.89
- NBY $0.58
- Average True Range (ATR)
- FUFU 0.53
- NBY 0.03
- MACD
- FUFU -0.09
- NBY -0.01
- Stochastic Oscillator
- FUFU 0.00
- NBY 36.27
About FUFU BITFUFU INC
BitFuFu Inc is a digital asset mining and cloud-mining service provider that fosters a secure, compliant, and transparent blockchain infrastructure. It provides stable and intelligent digital asset mining solutions, including one-stop cloud-mining services and miner hosting services to institutional customers and individual digital assets.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.